Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma has disclosed its upcoming schedule of meetings with analysts and institutional investors. Three meetings are planned: a one-on-one with Carnelian Asset Management on May 21, participation in 360 ONE Capital Investor Conference on May 27 (both one-on-one and group meetings), and a one-on-one with Ashmore Investment Management on May 29. This is a routine regulatory filing under SEBI LODR Regulation 30 to ensure transparency about investor interactions. The company notes these schedules may change due to exigencies.
This is a standard investor relations disclosure with no material information. Positive sign that the company actively engages with institutional investors, but unlikely to move the stock. Routine compliance filing.